Analyst Upgrades – Quest Diagnostics (NYSE:DGX) Stock Gets Upgraded By Argus from Hold to Buy

ME Staff
-
0

Analyst Ratings For Quest Diagnostics (NYSE:DGX)

Today, Quest Diagnostics (NYSE:DGX) stock received an upgrade by Argus from Hold to Buy with a price target of $116.00.

Some recent analyst ratings include

  • 3/7/2018-Argus Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 2/13/2018-Credit Suisse Group Upgrade from a “Neutral ” rating to a ” Outperform” rating.
  • 2/1/2018-Piper Jaffray Companies Reiterated Rating of Hold.
  • 1/29/2018-Goldman Sachs Group initiated coverage with a Buy rating.
  • 1/16/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 1/4/2018-Evercore ISI initiated coverage with a In rating.

Dividend information for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) pays an annual dividend of $1.80 with a yield of 1.73% and an average dividend growth of 11.70% based on a 3 Year Average..

Dividend History for Quest Diagnostics (NYSE:DGX)

  • On 2/1/2018 Quest Diagnostics announced a quarterly dividend of $0.50 0.00472500472500473% with an ex dividend date of 4/3/2018 which will be payable on 4/18/2018.
  • On 11/29/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.83% with an ex dividend date of 1/8/2018 which will be payable on 1/24/2018.
  • On 8/18/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.72% with an ex dividend date of 10/2/2017 which will be payable on 10/18/2017.
  • On 5/16/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.71% with an ex dividend date of 7/6/2017 which will be payable on 7/24/2017.
  • On 2/21/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.88% with an ex dividend date of 4/3/2017 which will be payable on 4/19/2017.
  • On 11/11/2016 Quest Diagnostics announced a quarterly dividend of $0.45 with an ex dividend date of 1/6/2017 which will be payable on 1/25/2017.
  • On 8/17/2016 Quest Diagnostics announced a quarterly dividend of $0.40 1.88% with an ex dividend date of 9/30/2016 which will be payable on 10/19/2016.

Recent Insider Trading Activity For Quest Diagnostics (NYSE:DGX)
Quest Diagnostics (NYSE:DGX) has insider ownership of 1.75% and institutional ownership of 87.40%.

  • On 3/5/2018 Catherine T Doherty, SVP, sold 5,556 with an average share price of $101.00 per share and the total transaction amounting to $561,156.00.
  • On 3/5/2018 J. E Davis, EVP, sold 5,122 with an average share price of $101.00 per share and the total transaction amounting to $517,322.00.
  • On 2/28/2018 Catherine T Doherty, SVP, sold 1,820 with an average share price of $104.38 per share and the total transaction amounting to $189,971.60.
  • On 2/28/2018 J. E Davis, EVP, sold 1,798 with an average share price of $104.42 per share and the total transaction amounting to $187,747.16.
  • On 2/26/2018 Catherine T Doherty, SVP, sold 397 with an average share price of $102.74 per share and the total transaction amounting to $40,787.78.
  • On 2/26/2018 J. E Davis, EVP, sold 494 with an average share price of $102.74 per share and the total transaction amounting to $50,753.56.
  • On 2/26/2018 Robert A Klug, VP, sold 1,157 with an average share price of $103.66 per share and the total transaction amounting to $119,934.62.

Recent Trading Activity for Quest Diagnostics (NYSE:DGX)
Shares of Quest Diagnostics closed the previous trading session at 104.39 up +0.26 0.25% with 113008 shares trading hands.